Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

RIPK4 activity in keratinocytes is controlled by the SCFβ-TrCP ubiquitin ligase to maintain cortical actin organization.

Tanghe G, Urwyler-Rösselet C, De Groote P, Dejardin E, De Bock PJ, Gevaert K, Vandenabeele P, Declercq W.

Cell Mol Life Sci. 2018 Aug;75(15):2827-2841. doi: 10.1007/s00018-018-2763-6. Epub 2018 Feb 12.

PMID:
29435596
2.

A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.

Boege Y, Malehmir M, Healy ME, Bettermann K, Lorentzen A, Vucur M, Ahuja AK, Böhm F, Mertens JC, Shimizu Y, Frick L, Remouchamps C, Mutreja K, Kähne T, Sundaravinayagam D, Wolf MJ, Rehrauer H, Koppe C, Speicher T, Padrissa-Altés S, Maire R, Schattenberg JM, Jeong JS, Liu L, Zwirner S, Boger R, Hüser N, Davis RJ, Müllhaupt B, Moch H, Schulze-Bergkamen H, Clavien PA, Werner S, Borsig L, Luther SA, Jost PJ, Weinlich R, Unger K, Behrens A, Hillert L, Dillon C, Di Virgilio M, Wallach D, Dejardin E, Zender L, Naumann M, Walczak H, Green DR, Lopes M, Lavrik I, Luedde T, Heikenwalder M, Weber A.

Cancer Cell. 2017 Sep 11;32(3):342-359.e10. doi: 10.1016/j.ccell.2017.08.010.

3.

Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation.

Seleznik GM, Reding T, Peter L, Gupta A, Steiner SG, Sonda S, Verbeke CS, Dejardin E, Khatkov I, Segerer S, Heikenwalder M, Graf R.

Gut. 2018 Sep;67(9):1663-1673. doi: 10.1136/gutjnl-2016-313458. Epub 2017 Aug 3.

PMID:
28774888
4.

Context-dependent roles for lymphotoxin-β receptor signaling in cancer development.

Fernandes MT, Dejardin E, dos Santos NR.

Biochim Biophys Acta. 2016 Apr;1865(2):204-19. doi: 10.1016/j.bbcan.2016.02.005. Epub 2016 Feb 27. Review.

PMID:
26923876
5.

Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype.

Fernandes MT, Ghezzo MN, Silveira AB, Kalathur RK, Póvoa V, Ribeiro AR, Brandalise SR, Dejardin E, Alves NL, Ghysdael J, Barata JT, Yunes JA, dos Santos NR.

Br J Haematol. 2015 Dec;171(5):736-51. doi: 10.1111/bjh.13760. Epub 2015 Oct 12. Erratum in: Br J Haematol. 2016 Jun;173(5):804.

PMID:
26456771
6.

NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling.

Dondelinger Y, Jouan-Lanhouet S, Divert T, Theatre E, Bertin J, Gough PJ, Giansanti P, Heck AJ, Dejardin E, Vandenabeele P, Bertrand MJ.

Mol Cell. 2015 Oct 1;60(1):63-76. doi: 10.1016/j.molcel.2015.07.032. Epub 2015 Sep 3.

7.

NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.

Boutaffala L, Bertrand MJ, Remouchamps C, Seleznik G, Reisinger F, Janas M, Bénézech C, Fernandes MT, Marchetti S, Mair F, Ganeff C, Hupalowska A, Ricci JE, Becher B, Piette J, Knolle P, Caamano J, Vandenabeele P, Heikenwalder M, Dejardin E.

Cell Death Differ. 2015 Dec;22(12):2020-33. doi: 10.1038/cdd.2015.69. Epub 2015 Jun 5.

8.

DUSP3 Genetic Deletion Confers M2-like Macrophage-Dependent Tolerance to Septic Shock.

Singh P, Dejager L, Amand M, Theatre E, Vandereyken M, Zurashvili T, Singh M, Mack M, Timmermans S, Musumeci L, Dejardin E, Mustelin T, Van Ginderachter JA, Moutschen M, Oury C, Libert C, Rahmouni S.

J Immunol. 2015 May 15;194(10):4951-62. doi: 10.4049/jimmunol.1402431. Epub 2015 Apr 15.

9.

A role for APPL1 in TLR3/4-dependent TBK1 and IKKε activation in macrophages.

Chau TL, Göktuna SI, Rammal A, Casanova T, Duong HQ, Gatot JS, Close P, Dejardin E, Desmecht D, Shostak K, Chariot A.

J Immunol. 2015 Apr 15;194(8):3970-83. doi: 10.4049/jimmunol.1401614. Epub 2015 Mar 16.

10.

Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.

Remouchamps C, Dejardin E.

Methods Mol Biol. 2015;1280:103-19. doi: 10.1007/978-1-4939-2422-6_7.

PMID:
25736746
11.

Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, Sprinzl MF, Koppensteiner H, Makowska Z, Volz T, Remouchamps C, Chou WM, Thasler WE, Hüser N, Durantel D, Liang TJ, Münk C, Heim MH, Browning JL, Dejardin E, Dandri M, Schindler M, Heikenwalder M, Protzer U.

Science. 2014 Mar 14;343(6176):1221-8. doi: 10.1126/science.1243462. Epub 2014 Feb 20.

12.

Noncanonical NF-κB signaling is limited by classical NF-κB activity.

Gray CM, Remouchamps C, McCorkell KA, Solt LA, Dejardin E, Orange JS, May MJ.

Sci Signal. 2014 Feb 4;7(311):ra13. doi: 10.1126/scisignal.2004557.

13.

RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.

Dondelinger Y, Aguileta MA, Goossens V, Dubuisson C, Grootjans S, Dejardin E, Vandenabeele P, Bertrand MJ.

Cell Death Differ. 2013 Oct;20(10):1381-92. doi: 10.1038/cdd.2013.94. Epub 2013 Jul 26.

14.

Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system.

Remouchamps C, Boutaffala L, Ganeff C, Dejardin E.

Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):301-10. doi: 10.1016/j.cytogfr.2011.11.007. Review.

PMID:
22152226
15.

Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor.

Ganeff C, Remouchamps C, Boutaffala L, Benezech C, Galopin G, Vandepaer S, Bouillenne F, Ormenese S, Chariot A, Schneider P, Caamaño J, Piette J, Dejardin E.

Mol Cell Biol. 2011 Nov;31(21):4319-34. doi: 10.1128/MCB.05033-11. Epub 2011 Sep 6.

16.

Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-kappaB activation.

Mortier J, Frederick R, Ganeff C, Remouchamps C, Talaga P, Pochet L, Wouters J, Piette J, Dejardin E, Masereel B.

Biochem Pharmacol. 2010 May 15;79(10):1462-72. doi: 10.1016/j.bcp.2010.01.007. Epub 2010 Jan 21.

PMID:
20096267
17.

Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.

Robert I, Aussems M, Keutgens A, Zhang X, Hennuy B, Viatour P, Vanstraelen G, Merville MP, Chapelle JP, de Leval L, Lambert F, Dejardin E, Gothot A, Chariot A.

Oncogene. 2009 Apr 2;28(13):1626-38. doi: 10.1038/onc.2009.6. Epub 2009 Feb 16.

18.

The prevention of spontaneous apoptosis of follicular lymphoma B cells by a follicular dendritic cell line: involvement of caspase-3, caspase-8 and c-FLIP.

Goval JJ, Thielen C, Bourguignon C, Greimers R, Dejardin E, Choi YS, Boniver J, de Leval L.

Haematologica. 2008 Aug;93(8):1169-77. doi: 10.3324/haematol.12127. Epub 2008 Jun 12.

19.

Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cells.

Cornez I, Creppe C, Gillard M, Hennuy B, Chapelle JP, Dejardin E, Merville MP, Close P, Chariot A.

Biochem Pharmacol. 2008 Jun 1;75(11):2122-34. doi: 10.1016/j.bcp.2008.03.006. Epub 2008 Mar 15.

20.

Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.

El Mjiyad N, Bontems S, Gloire G, Horion J, Vandevenne P, Dejardin E, Piette J, Sadzot-Delvaux C.

J Virol. 2007 Dec;81(23):13092-104. Epub 2007 Sep 12. Erratum in: J Virol. 2008 Apr;82(8):4191.

21.

Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF.

Gatot JS, Gioia R, Chau TL, Patrascu F, Warnier M, Close P, Chapelle JP, Muraille E, Brown K, Siebenlist U, Piette J, Dejardin E, Chariot A.

J Biol Chem. 2007 Oct 26;282(43):31131-46. Epub 2007 Sep 6.

22.

Promoter-dependent effect of IKKalpha on NF-kappaB/p65 DNA binding.

Gloire G, Horion J, El Mjiyad N, Bex F, Chariot A, Dejardin E, Piette J.

J Biol Chem. 2007 Jul 20;282(29):21308-18. Epub 2007 May 30.

23.

Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells.

Lambert C, Oury C, Dejardin E, Chariot A, Piette J, Malaise M, Merville MP, Franchimont N.

J Bone Miner Res. 2007 Sep;22(9):1350-61.

24.

The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.

Dejardin E.

Biochem Pharmacol. 2006 Oct 30;72(9):1161-79. Epub 2006 Sep 12. Review.

PMID:
16970925
25.

Extending the nuclear roles of IkappaB kinase subunits.

Gloire G, Dejardin E, Piette J.

Biochem Pharmacol. 2006 Oct 30;72(9):1081-9. Epub 2006 Jul 18. Review.

26.

Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1.

Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR.

Mol Cell. 2006 Mar 17;21(6):749-60.

27.

GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity.

Viatour P, Dejardin E, Warnier M, Lair F, Claudio E, Bureau F, Marine JC, Merville MP, Maurer U, Green D, Piette J, Siebenlist U, Bours V, Chariot A.

Mol Cell. 2004 Oct 8;16(1):35-45.

28.
29.

RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100.

Derudder E, Dejardin E, Pritchard LL, Green DR, Korner M, Baud V.

J Biol Chem. 2003 Jun 27;278(26):23278-84. Epub 2003 Apr 21.

30.

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways.

Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR.

Immunity. 2002 Oct;17(4):525-35.

31.

Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.

Bentires-Alj M, Dejardin E, Viatour P, Van Lint C, Froesch B, Reed JC, Merville MP, Bours V.

Oncogene. 2001 May 17;20(22):2805-13.

32.

Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells.

Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP, Bours V.

Oncogene. 1999 Apr 22;18(16):2567-77.

33.

Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells.

Dejardin E, Deregowski V, Greimers R, Cai Z, Chouaib S, Merville MP, Bours V.

Oncogene. 1998 Jun 25;16(25):3299-307.

34.

Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates.

Bonizzi G, Dejardin E, Piret B, Piette J, Merville MP, Bours V.

Eur J Biochem. 1996 Dec 15;242(3):544-9.

35.

Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.

Dejardin E, Bonizzi G, Bellahcène A, Castronovo V, Merville MP, Bours V.

Oncogene. 1995 Nov 2;11(9):1835-41.

PMID:
7478612
36.

Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins.

Bours V, Azarenko V, Dejardin E, Siebenlist U.

Oncogene. 1994 Jun;9(6):1699-702.

PMID:
8183565
37.

The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines.

Bours V, Dejardin E, Goujon-Letawe F, Merville MP, Castronovo V.

Biochem Pharmacol. 1994 Jan 13;47(1):145-9.

PMID:
8311838

Supplemental Content

Loading ...
Support Center